CAPTRUST Financial Advisors
EBS icon

CAPTRUST Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,772
Closed -$86K – 2610
2022
Q2 		$86K Buy
2,772
+906
+49% +$30.9K ﹤0.01% 2319
2022
Q1 		$77K Sell
1,866
-70
-4% -$3.09K ﹤0.01% 2465
2021
Q4 		$84K Buy
1,936
+602
+45% +$27.2K ﹤0.01% 2295
2021
Q3 		$67K Sell
1,334
-132
-9% -$7.99K ﹤0.01% 2374
2021
Q2 		$92K Sell
1,466
-171
-10% -$11K ﹤0.01% 2092
2021
Q1 		$152K Sell
1,637
-2,218
-58% -$227K ﹤0.01% 1666
2020
Q4 		$345K Buy
3,855
+3,500
+986% +$321K ﹤0.01% 959
2020
Q3 		$38K Sell
355
-2,410
-87% -$260K ﹤0.01% 1727
2020
Q2 		$226K Buy
+2,765
New +$206K ﹤0.01% 978
2019
Q4 		– Sell
-219
Closed -$11K – 1219
2019
Q3 		$11K Sell
219
-87
-28% -$4.05K ﹤0.01% 1461
2019
Q2 		$15K Buy
306
+230
+303% +$11K ﹤0.01% 1368
2019
Q1 		$4K Buy
76
+34
+81% +$2.01K ﹤0.01% 1570
2018
Q4 		$2K Buy
+42
New +$2.71K ﹤0.01% 1478

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CAPTRUST Financial Advisors's EBS Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 2,772 shares — an estimated $86K sold.

CAPTRUST Financial Advisors first reported a position in EBS in Q4 2018 and held it in 13 quarters. The position peaked at $345K in Q4 2020. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,772 Emergent Biosolutions shares in Q3 2022, an estimated $86K.
  • CAPTRUST Financial Advisors first reported a position in Emergent Biosolutions in Q4 2018 and held it in 13 quarters.
  • CAPTRUST Financial Advisors's Emergent Biosolutions position peaked at $345K in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.